.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Cerilliant
Fish and Richardson
Deloitte
Novartis
Express Scripts
Covington
Chubb
Boehringer Ingelheim

Generated: June 26, 2017

DrugPatentWatch Database Preview

THEOPHYLLINE Drug Profile

« Back to Dashboard

What is the patent landscape for Theophylline, and when can generic versions of Theophylline launch?

Theophylline is a drug marketed by Alpharma Us Pharms, Pliva, Pharm Assoc, Taro, Alembic Pharms Ltd, Scherer Rp, Hospira, Inwood Labs, Teva Pharms, Roxane, Able, Wockhardt, Chartwell Rx, Cent Pharms, Glenmark Generics, Silarx, Mylan Ireland Ltd, Sandoz, Kv Pharm, Precision Dose, Halsey, Rhodes Pharms, Cenci, Tris Pharma Inc, B Braun, Baxter Hlthcare, and Hospira Inc. and is included in forty-four NDAs.

The generic ingredient in THEOPHYLLINE is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for Tradename: THEOPHYLLINE

Patents:0
Applicants:27
NDAs:44
Suppliers / Packagers: see list24
Bulk Api Vendors: see list84
Clinical Trials: see list75
Patent Applications: see list9,768
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:THEOPHYLLINE at DailyMed

Pharmacology for Tradename: THEOPHYLLINE

Ingredient-typeXanthines
Drug ClassMethylxanthine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION019211-006Jan 20, 1988APRXYesYes► Subscribe► Subscribe
Rhodes Pharms
THEOPHYLLINE
theophylline
TABLET, EXTENDED RELEASE;ORAL087571-001Sep 1, 1982ABRXNoNo► Subscribe► Subscribe
Silarx
THEOPHYLLINE
theophylline
SOLUTION;ORAL091156-001Apr 13, 2011AARXNoYes► Subscribe► Subscribe
B Braun
THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION019083-001Nov 7, 1984DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION018649-007Jul 26, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Novartis
US Department of Justice
Boehringer Ingelheim
Federal Trade Commission
Chubb
Cantor Fitzgerald
Moodys
Deloitte
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot